dFdU, DrugMetabolite, Drug Metabolite, 2,2-Difluoro-2-deoxyuridine
2',2'-Difluorodeoxyuridine (dFdU) is the primary metabolite of the chemotherapeutic agent Gemcitabine. It exhibits anticancer and radiosensitizing properties, particularly under hypoxic conditions, making it a relevant compound for in vitro and in vivo research in oncology, including pancreatic cancer studies.